Search results for " MAST"

showing 10 items of 182 documents

Systemic mastocytosis. A GIMEMA multicenter survey

2006

Abstract To evaluate clinical and biological features, treatments and outcome of patients(pts) with Systemic Mastocytosis(SM). A retrospective study (1995–2006) about pts with SM admitted in 14 Italian hematology divisions in tertiary cares or university hospitals. 30 cases of SM were collected(median age 62 y.o.; M/F 14/16) and classified according to the WHO criteria: Mast Cell Leukemia in 14 pts, Aggressive SM in 12 and Indolent in 3; the remaining one had SM with associated clonal non-mast cell-lineage hematologic disease. Skin was the principal extramedullary organ involved (19 pts) followed by spleen(15), liver(13), and cardiovascular system(12). Molecular biology studies were perform…

medicine.medical_specialtyHematologybusiness.industrymedicine.medical_treatmentImmunologyAlpha interferonRetrospective cohort studyImatinibCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseMast cell leukemiaBiochemistryGastroenterologySurgeryHematologic diseaseInternal medicinemedicineSystemic mastocytosisbusinessmedicine.drug
researchProduct

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-contro…

2009

Background Mastocytosis is characterized by the accumulation and activation of mast cells in different organs, most commonly the skin. Miltefosine, a raft modulator, has recently been shown to inhibit the activation of mast cells and to reduce mast cell-driven skin inflammatory responses. Objectives To study the safety and efficacy of topical miltefosine treatment of skin lesions in patients with mastocytosis. Methods Thirty-nine adult patients with mastocytosis with skin involvement were treated in a double-blind, placebo-controlled, parallel trial with topical miltefosine and clobetasol for 2 weeks. Treatment areas were analysed for changes in skin lesions and symptoms following mechanica…

medicine.medical_specialtyMiltefosinebusiness.industryCutaneous MastocytosisProvocation testPlacebo-controlled studyDermatologyMast cellDermatologylaw.inventionmedicine.anatomical_structurePharmacotherapyRandomized controlled trialDermislawMedicinebusinessmedicine.drugBritish Journal of Dermatology
researchProduct

The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE)

2005

The social perception of headache, everywhere at low levels in industrialised countries, becomes totally absent in developing ones. Headache disorders came into the World Health Organization’s strategic priorities after publication of the 2001 World Health Report. Among the leading causes of disability, migraine was ranked 19th for adults of both sexes together and 12th for females. The Global Campaign (GC) to Reduce the Burden of Headache Worldwide was planned by the major international headache organizations together with WHO in order to identify and remove those cultural, social and educational barriers recognised as responsible factors for the inadequate treatment of headache disorders …

medicine.medical_specialtyPain medicineeducationClinical SciencesGlobal Campaign Against HeadacheClinical NeurologyAlternative medicineMEDLINEWorld Health OrganizationGlobal Healthmasterin headache medicineWorld healthEducationMigrainesClinical ResearchMedicalacademic formation; global campaign against headache; headache specialist education; masterin headache medicineHealth careGeneticsGlobal healthHumansMedicineHeadache specialist educationDental/Oral and Craniofacial DiseaseGraduateNeurology & NeurosurgeryHeadachesbusiness.industrySocial perceptionPain ResearchHeadacheNeurosciencesMaster in Headache MedicineGeneral Medicinemedicine.diseaseHeadaches Physicians and PatientsAcademic formationQuality EducationAnesthesiology and Pain MedicineNeurologyMigraineEducation Medical GraduateFamily medicineNeurology (clinical)Chronic PainbusinessThe Journal of Headache and Pain
researchProduct

Onkoplastische Sofortrekonstruktions-Technik unter Erhalt des Mamillen-Areola-Komplexes nach radikaler Resektion eines Mammakarzinoms mit zentralem S…

2001

There are few breast-conserving therapies (BCT) for centrally located breast cancer. The present paper describes a BCT for breast cancers in such a location, which permits conservation of the nipple-areola complex (NAC), provided this has not been infiltrated. After histological detection of the breast cancer by punch biopsy, a central segmental mastectomy and an axillary dissection are performed. An immediate reconstruction of the subareolar defect is carried out by means of a local flap technique, thus conserving the NAC.

medicine.medical_specialtyPunch Biopsymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentObstetrics and GynecologySegmental Mastectomymedicine.diseaseSurgeryBreast cancerBiopsymedicineAxillary DissectionSurgical Flapsskin and connective tissue diseasesRadical resectionbusinessMastectomyZentralblatt für Gynäkologie
researchProduct

Male breast cancer: Reconstructive surgery

2020

The conventional treatment for male breast cancer consists of modified radical mastectomy with axillary sentinel node biopsy and/or axillary lymph node dissection in case of lymph node-positive disease. However, breast-conserving surgery (BCS) is gaining popularity also among men. In both cases, surgery leaves an aesthetic disfigurement that impacts patient well-being and quality of life. Thus, even if male breast has a different social and emotional role than female’s one, male breast reconstruction deserves the same importance. The aim of this chapter is to give a comprehensive review on latest indications and strategies for the post-oncological reconstructive surgery of the male breast.

medicine.medical_specialtyReconstructive surgerymedicine.diagnostic_testbusiness.industryConventional treatmentAxillary Lymph Node DissectionSettore MED/19 - Chirurgia PlasticaSentinel nodeModified Radical Mastectomymedicine.diseaseSurgeryMale breast cancerMale chest wall reconstructionMale breast cancerBiopsymedicineLymphskin and connective tissue diseasesbusinessMale breast reconstruction
researchProduct

Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis w…

2019

Background: The gain-of function mutation KIT D816V plays a central role in the pathogenesis of systemic mastocytosis (SM). Among subtypes of SM, indolent SM (ISM) is the most frequent and is associated with normal/near-normal life expectancy; smoldering SM (SSM) is a subtype with a relatively higher burden of mast cells and may be associated with an increased risk of progression to advanced mastocytosis. However, both ISM and SSM patients may experience severe symptoms associated with mast cell mediator release, such as pruritus, diarrhea, anaphylaxis, and bone pain, which can be severely debilitating and have a profoundly negative impact on quality of life. Symptomatic treatments (eg, ant…

medicine.medical_specialtybusiness.industrySurrogate endpointImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseasePlaceboBiochemistryDouble blindInternal medicineMedicineIn patientSystemic mastocytosismedicine.symptombusinessBone painAsthmaBlood
researchProduct

Skin-nipple-sparing mastectomy: The first approach in primary myxoid chondrosarcoma of the breast

2017

Abstract The primary mammary chondrosarcoma corresponds to less than 0,5% of the mammary malignancies. For the period ranging from 1967 to 2014, only 18 cases were reported in the literature. A 41 year old woman found a hard nodule on her external right superior quadrant/axillary prolongation through breast self-examination. The vacuum-assisted core biopsy (VACB) revealed “high grade extra-skeletal myxoid chondrosarcoma”. A skin-nipple-sparing mastectomy with the insertion of a mammary expander was performed. A protocol of adjuvant radiotherapy was also indicated. Until 2013, the gold standard was the radical mastectomy. By 2014, there were two cases of conservative approach to quadrantecto…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentSkin nippleCase Reportmedicine.diseaseMyxoid chondrosarcomaSurgery03 medical and health sciencesQuadrant (abdomen)Myxoid chondrosarcoma of the breast0302 clinical medicineBreast cancerBreast cancer030220 oncology & carcinogenesisSkin-nipple-sparing mastectomymedicine030211 gastroenterology & hepatologySurgeryChondrosarcomabusinessQuadrantectomyMastectomyRadical mastectomyInternational Journal of Surgery Case Reports
researchProduct

Resting sympatho-vagal balance is related to 10 km running performance in master endurance athletes

2018

Relationships between heart rate recovery after exercise (HRR, baseline heart rate variability measures (HRV), and time to perform a 10Km running trial (t10Km) were evaluated in "master" athletes of endurance to assess whether the measured indexes may be useful for monitoring the training status of the athletes. Ten “master” athletes of endurance, aged 40-60 years, were recruited. After baseline measures of HRV, the athletes performed a graded maximal test on treadmill and HRR was measured at 1 and 2 minutes from recovery. Subsequently they performed a 10Km running trial and t10Km was related to HRV and HRR indexes. The time to perform a 10Km running trial was significantly correlated with …

medicine.medical_specialtylcsh:Medicine02 engineering and technologyArticlelcsh:QM1-69503 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmaster athletesendurance trainingEndurance trainingHeart rate0202 electrical engineering electronic engineering information engineeringAutonomic nervous system; Endurance training; Heart rate recovery; Heart rate variability; Master athletes commercial; Neurology (clinical); Orthopedics and Sports Medicine; Cell Biology; Molecular BiologyMedicineHeart rate variabilityMaster athletes commercialheart rate recovery heart rate variability autonomic nervous system endurance training master athletesOrthopedics and Sports MedicineTreadmillMolecular BiologyBalance (ability)biologyAthletesbusiness.industryautonomic nervous systemlcsh:Rheart rate variability020206 networking & telecommunications030229 sport sciencesCell Biologylcsh:Human anatomybiology.organism_classificationHeart rate recoveryNeurology (clinical)businesshuman activitiesEuropean Journal of Translational Myology
researchProduct

Evaluation of routine follow-up after surgery for breast carcinoma.

1986

Close postoperative follow-up of patients with breast cancer permits the early detection of possible recurrence of disease. Such follow-up allows for the detection of a tumor mass, that is small enough to permit adequate treatment leading to an increased survival time and better quality of life. Thus we studied 85 patients treated by radical mastectomy in stages I, II, and III during the period from December 1977 to June 1982. Among 82 patients, 41 had axillary node involvement and received adjuvant chemotherapy with C.M.F. All patients received a strict follow-up. Thirty-two patients showed recurrence of the disease, with 28. 1% being discovered while still asymptomatic. Seventy-five perce…

medicine.medical_specialtymedicine.medical_treatmentMammary glandEarly detectionBreast NeoplasmsDiseaseAsymptomaticBreast cancerQuality of lifeMedicineHumansNeoplasm MetastasisRadical mastectomyPostoperative Carebusiness.industryGeneral Medicinemedicine.diseaseSurgerymedicine.anatomical_structureOncologySurgeryFemalemedicine.symptomNeoplasm Recurrence LocalbusinessBreast carcinomaFollow-Up StudiesJournal of surgical oncology
researchProduct

Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients

2005

Abstract Purpose The aim of this study is to describe the University of Florence experience in evaluating clinical, pathologic and treatment factors as they are related to the outcome and loco-regional recurrence in patients with tubular breast carcinoma. Material and methods Three hundred and seven patients (median age 56.4 years, range 26–91 years) with histological verified tubular carcinoma of the breast were consecutively treated at University of Florence from 1976 to 2001. All patients were followed for a median of 8.4 years (range 3 months to 20 years). Thirty-seven women underwent mastectomy and 270 underwent breast conserving surgery. Positive axillary nodes were found in 15% of pa…

medicine.medical_treatmentDiseaseSegmentalMastectomy SegmentalBreast cancerDuctalBreast-conserving surgery80 and overBreastAdjuvantMastectomyAged 80 and overCarcinoma Ductal BreastTubular carcinomaGeneral MedicineMiddle AgedCombined Modality TherapyTreatment OutcomeBreast cancer; Radiotherapy; Tubular carcinoma; Adenocarcinoma; Adult; Aged; Aged 80 and over; Antineoplastic Agents Hormonal; Axilla; Breast Neoplasms; Carcinoma Ductal Breast; Chemotherapy Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Mastectomy; Mastectomy Segmental; Middle Aged; Neoplasm Recurrence Local; Proportional Hazards Models; Radiotherapy Adjuvant; Survival Analysis; Tamoxifen; Treatment Outcome; Oncology; SurgeryLocalOncologyChemotherapy AdjuvantLymphatic MetastasisFemaleMastectomymedicine.drugAdultmedicine.medical_specialtyAntineoplastic Agents HormonalAntineoplastic AgentsBreast NeoplasmsAdenocarcinomaBreast cancermedicineChemotherapyHumansAgedProportional Hazards ModelsChemotherapyRadiotherapyHormonalbusiness.industryCarcinomamedicine.diseaseSurvival AnalysisSurgeryRadiation therapyTamoxifenNeoplasm RecurrenceAxillaRadiotherapy AdjuvantSurgeryTubular carcinomaNeoplasm Recurrence LocalbusinessTamoxifen
researchProduct